Skip to main content

Table 6 Mortality and mRS and characteristics of the patients

From: Incidence and predictive factors of diaphragmatic dysfunction in acute stroke

 

Mortality

mRS

Mortality n (%)

No n (%)

p

Good pr. n (%)

Poor pr. n (%)

p

Female sex

3 (10.3)

26 (89.7)

0.666

19 (65.5)

10 (34.5)

0.855

Hypertension

4 (10.5)

34 (89.5)

0.643

23 (60.5)

15 (39.5)

0.185

Dyslipidaemia

3 (10.7)

25 (89.3)

0.533

17 (60.7)

11 (39.3)

0.360

Diabetes

3 (16.7)

15 (83.3)

0.154

10 (55.6)

8 (44.4)

0.232

Smoking

0

20 (100)

0.099

18 (90)

2 (10)

0.008

Poor performance status

3 (12.5)

21 (87.5)

0.380

14 (58.3)

10 (41.7)

0.264

Previous severe dyspnoea

0

3 (100)

1

1 (33.3)

2 (66.7)

0.255

COPD

0

4 (100)

1

2 (50)

2 (50)

0.595

SAHS

0

6 (100)

1

4 (66.7)

2 (33.3)

1

Cardioembolic origin

0

42 (100)

0.002

32 (76.2)

10 (23.8)

0.034

Sensory aphasia

1 (20)

4 (80)

0.363

0

5 (100)

0.003

Reperfusion treatment

3 (12)

22 (82)

0.640

15 (60)

10 (40)

0.412

Severe hemiparesis

1 (2.1)

47 (97.9)

0.004

38 (79.2)

10 (20.8)

<  0.001

Age, mean ± SD

69.5 ± 10.5

68.9 ± 9.4

0.872

67.2 ± 8.9

73.4 ± 10.1

0.288

NIHSS, median [25%:75%]

21 [18.5:24]

4 [3:9]

<  0.001

4 [2:8]

10 [5:20]

0.006

TF basal breathing %, mean ± SD

0.14 ± 0.04

0.28 ± 0.19

<  0.001

0.31 ± 0.20

0.19 ± 0.13

0.004

TF forced inspiration %, mean ± SD

0.40 ± 0.06

0.48 ± 0.25

0.143

0.51 ± 0.26

0.40 ± 0.20

0.061

Mortality

0

5 (100)

0.003

RI

5 (8.3)

28 (84.8)

0.043

17 (51.7)

16 (48.5)

0.007

  1. The table shows the association between mortality and mRS at 3 months and the demographic and clinical characteristics of the patients. The statistically significant results are highlighted in bold
  2. COPD Chronic Obstructive Pulmonary Disease, IQ Interquartile range, mRS Modified Rankin Scale, NIHSS National Institutes of Health Stroke Scale, pr Prognosis, RI Respiratory impairment, SAHS Sleep Apnoea-Hypopnoea Syndrome, SD Standard deviation, TF Thickening fraction